What does N G Industries do?

N G Industries Ltd provides medical services in the healthcare sector as a micro-cap company, reporting net sales of 4 Cr and a net loss of 2 Cr for the quarter ending March 2025. The company has a market cap of Rs 54 Cr and key metrics include a P/E of 7.00 and a dividend yield of 2.19%.

Overview:<BR>N G Industries Ltd is engaged in providing medical services within the healthcare services industry and operates as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in an unspecified year and has undergone no notable status changes. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 4 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 54 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 7.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 2.19% <BR>Debt-Equity: -0.10 <BR>Return on Equity: 18.58% <BR>Price to Book: 1.29 <BR><BR>Contact Details:<BR>Address: 1st Floor, 37 A Southern Avenue Kolkata West Bengal : 700029 <BR>Phone: 91-33-24197542 <BR>Email: ngmail@vsnl.com <BR>Website: http://www.ngind.com

Has N G Industries declared dividend?

N G Industries Ltd has declared a 35% dividend, amounting to 3.5 per share, with an ex-date of September 20, 2024. The company has shown strong total returns over various periods, particularly over the long term, with significant price appreciation and increasing dividend returns.

N G Industries Ltd has declared a 35% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 35%<BR>- Amount per share: 3.5<BR>- Ex-date: Sep-20-2024<BR><BR>Dividend Yield: 2.19%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -4.82%, the dividend return was 0%, resulting in a total return of -4.82%.<BR><BR>Over the past year, the price return was 1.62%, the dividend return was 2.29%, leading to a total return of 3.91%.<BR><BR>In the 2-year period, the price return was 77.94%, the dividend return was 7.92%, culminating in a total return of 85.86%.<BR><BR>For the last 3 years, the price return was 131.55%, the dividend return was 16.19%, resulting in a total return of 147.74%.<BR><BR>In the 4-year period, the price return was 241.88%, the dividend return was 19.57%, leading to a total return of 261.45%.<BR><BR>Over the past 5 years, the price return was 237.91%, the dividend return was 22.36%, resulting in a total return of 260.27%.<BR><BR>Overall, N G Industries has declared a substantial dividend, and the total returns over various periods indicate strong performance, particularly over the longer term, with significant price appreciation and increasing dividend returns.

What is the technical trend for N G Industries?

As of May 30, 2025, N G Industries has shifted to a bearish technical trend, supported by a bearish MACD, moving averages, and KST, with the Bollinger Bands indicating a mildly bearish condition and RSI showing no momentum.

As of 30 May 2025, the technical trend for N G Industries has changed from mildly bearish to bearish. The weekly MACD indicates a bearish stance, while the daily moving averages also confirm a bearish outlook. The KST on a weekly basis is bearish, further supporting this negative trend. The Bollinger Bands show a mildly bearish condition on the weekly chart, and both the weekly and monthly RSI indicate no signal, suggesting a lack of momentum. Overall, the current technical stance is bearish with a moderate strength, driven primarily by the bearish MACD and moving averages.

Who are the peers of the N G Industries?

N G Industries' peers include Royal Sense, Jeevan Scienti., Centenial Surgic, and others. In terms of management risk, Royal Sense and Amkay Products are excellent, while N G Industries has average risk; Aspira Pathlab leads in 1-year return at 64.58%, with N G Industries at -10.25%.

Peers: The peers of N G Industries are Royal Sense, Jeevan Scienti., Centenial Surgic, Aspira Pathlab, Amkay Products, Deccan Healthcar, Bandaram Pharma, KMS Medisurgi, and Medinova Diagno.<BR><BR>Quality Snapshot: Excellent management risk is observed at Royal Sense and Amkay Products, while Average management risk is found at Jeevan Scienti., Bandaram Pharma, KMS Medisurgi, and N G Industries. Below Average management risk is noted for Centenial Surgic, Aspira Pathlab, Deccan Healthcar, and the rest. In terms of Growth, Excellent growth is seen at Royal Sense and Bandaram Pharma, while Average growth is noted for Amkay Products, N G Industries, and KMS Medisurgi. Below Average growth is present at Jeevan Scienti., Centenial Surgic, Aspira Pathlab, Deccan Healthcar, and the rest. For Capital Structure, Excellent is noted at Royal Sense, while Good is found at N G Industries, Centenial Surgic, Deccan Healthcar, and KMS Medisurgi, with Average at Aspira Pathlab and Amkay Products, and Below Average at Bandaram Pharma.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aspira Pathlab at 64.58%, while the lowest is Deccan Healthcar at -42.18%. N G Industries has a 1-year return of -10.25%, which is higher than Deccan Healthcar's but lower than Aspira Pathlab's. Additionally, the six-month return is negative for Deccan Healthcar, Bandaram Pharma, and Aspira Pathlab.

Who are in the management team of N G Industries?

As of March 2020, the management team of N G Industries includes Raj Kumar Bajoria and Jagdish Chand Kumbhat as Non-Executive & Independent Directors, Rajesh Goenka as Chairman & Wholetime Director, Neha Goenka as Non-Executive & Non-Independent Director, and Dipak Kumar Shaw as Company Secretary.

As of March 2020, the management team of N G Industries includes the following members:<BR><BR>1. Raj Kumar Bajoria - Non-Executive & Independent Director<BR>2. Jagdish Chand Kumbhat - Non-Executive & Independent Director<BR>3. Rajesh Goenka - Chairman & Wholetime Director<BR>4. Neha Goenka - Non-Executive & Non-Independent Director<BR>5. Dipak Kumar Shaw - Company Secretary<BR><BR>These individuals play various roles within the company's governance and management structure.

Who are the top shareholders of the N G Industries?

The top shareholder of N G Industries is Ritu Goenka, holding 20.89% of the shares, with no pledged promoter holdings. The highest public shareholder is Kalpesh Manherlal Chokhawala at 1.04%, while individual investors collectively own 23.11%.

The top shareholders of N G Industries primarily consist of promoters, with Ritu Goenka holding the highest stake at 20.89%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Additionally, the highest public shareholder is Kalpesh Manherlal Chokhawala, who owns 1.04%. Individual investors collectively hold 23.11% of the shares.

How big is N G Industries?

As of 24th July, N G Industries Ltd has a market capitalization of 54.00 Cr, with recent net sales of 16.55 Cr and a net profit of 7.75 Cr. Shareholder's funds are 36.14 Cr, and total assets amount to 39.92 Cr.

As of 24th July, N G Industries Ltd has a market capitalization of 54.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, N G Industries reported Net Sales of 16.55 Cr and a Net Profit of 7.75 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 36.14 Cr and Total Assets of 39.92 Cr.

When is the next results date for N G Industries?

N G Industries will declare its results on 12 August 2025.

N G Industries will declare its results on 12 August 2025.

Should I buy, sell or hold N G Industries?

Are N G Industries latest results good or bad?

N G Industries' latest results show mixed performance, with a 126.32% sequential increase in net profit and 9.46% revenue growth, but an 85.52% year-on-year decline in net profit and a 7.53% drop in revenue indicate underlying issues. Overall, the results lean negative, leading to a "Strong Sell" recommendation for investors.

The latest results for N G Industries indicate a mixed performance, but overall, they lean towards the negative side. While the company reported a sequential increase in net profit of 126.32% and a revenue growth of 9.46% compared to the previous quarter, these figures are overshadowed by a significant year-on-year decline. Specifically, net profit has plummeted by 85.52% from ₹2.97 crores in Q2 FY25 to just ₹0.43 crores in Q2 FY26, and revenue has decreased by 7.53% compared to the same quarter last year.<BR><BR>Additionally, the operating margin has contracted to 8.15%, down from 10.27% in the same quarter last year, indicating rising cost pressures that the company has not managed to offset. The company's reliance on "other income" to bolster profitability raises concerns about the sustainability of its earnings, as this income exceeded the operating profit in the latest quarter.<BR><BR>Overall, while there are some positive signs in terms of sequential growth, the substantial year-on-year declines and operational challenges suggest that the latest results are more indicative of underlying issues rather than a solid recovery or growth trajectory. The recommendation for investors is a "Strong Sell," reflecting these concerns.

How has been the historical performance of N G Industries?

N G Industries has experienced fluctuating financial performance, with a decline in net sales from INR 18.70 crore in March 2023 to INR 16.55 crore in March 2025, while profits also decreased; however, the company's reserves and total assets increased, indicating a strengthening financial position despite revenue challenges.

Answer:<BR>The historical performance of N G Industries shows fluctuations in key financial metrics over the years, with notable trends in revenue, profit, and asset management.<BR><BR>Breakdown:<BR>N G Industries experienced a decline in net sales from INR 18.70 crore in March 2023 to INR 16.55 crore in March 2025, following a peak of INR 18.88 crore in March 2024. The total operating income mirrored this trend, decreasing from INR 18.70 crore in March 2023 to INR 16.55 crore in March 2025. Operating profit (PBDIT) also saw a decline, reaching INR 9.80 crore in March 2025, down from INR 10.18 crore in March 2023. Profit before tax fluctuated, peaking at INR 9.65 crore in March 2023 before dropping to INR 9.14 crore in March 2025. Profit after tax followed a similar pattern, with a high of INR 8.32 crore in March 2023 and a subsequent decrease to INR 7.74 crore in March 2025. The company's reserves increased significantly from INR 24.85 crore in March 2023 to INR 35.17 crore in March 2025, indicating a strengthening of the financial position despite the revenue decline. Total assets rose from INR 30.72 crore in March 2023 to INR 39.92 crore in March 2024, reflecting growth in shareholder's funds and non-current investments. Cash flow from operating activities showed variability, with a negative cash flow of INR 1 crore in March 2024, while cash and cash equivalents increased to INR 2 crore by the end of March 2024. Overall, while N G Industries faced challenges in revenue generation, it demonstrated resilience in profit margins and asset growth.

Is N G Industries overvalued or undervalued?

As of November 10, 2025, N G Industries is considered an attractive investment due to its undervalued status, reflected in a low PE ratio of 9.24 and a PEG ratio of 0.00, despite recent underperformance against the Sensex.

As of 10 November 2025, the valuation grade for N G Industries has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued, particularly when considering its low PE ratio of 9.24, a price to book value of 0.12, and an EV to EBITDA ratio of 19.50. These ratios suggest that the stock is trading at a significant discount compared to its earnings and asset value.<BR><BR>In comparison to its peers, N G Industries stands out with a much lower PE ratio than Max Healthcare, which has a PE of 88.71, and Apollo Hospitals at 64.78. The PEG ratio for N G Industries is notably at 0.00, indicating potential growth at a very low price relative to its earnings growth. Despite recent underperformance against the Sensex, with a year-to-date return of -24.92% compared to the Sensex's 6.91%, the fundamental ratios suggest that N G Industries remains an attractive investment opportunity in the healthcare services sector.

Why is N G Industries falling/rising?

As of 13-Dec, N G Industries Ltd's stock price is rising to 129.10, with a 0.19% increase. This upward trend is supported by a recent 5.86% return over four days and increased investor participation, although it still lags behind its sector and longer-term moving averages.

As of 13-Dec, N G Industries Ltd's stock price is rising, currently at 129.10, with a change of 0.25 (0.19%) upward. This increase can be attributed to several factors. The stock has been gaining for the last four days, resulting in a total return of 5.86% during this period. Additionally, there has been a notable rise in investor participation, as evidenced by a delivery volume of 317 on 11 Dec, which has increased by 111.05% compared to the 5-day average delivery volume. <BR><BR>Despite this positive momentum, it is important to note that the stock has underperformed its sector today by 0.74%. Furthermore, while the stock is currently higher than its 5-day moving averages, it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages, indicating that there may still be challenges ahead. Overall, the recent gains and increased investor interest are contributing to the stock's upward movement.

Which are the latest news on N G Industries?